Literature DB >> 15744457

Association of eotaxin-2 gene polymorphisms with plasma eotaxin-2 concentration.

Ji-Won Min1, June-Hyuk Lee1, Choon-Sik Park2, Hun Soo Chang1, Tai Youn Rhim1, Sung-Woo Park1, An-Soo Jang1, Hyoung-Doo Shin3.   

Abstract

Chemokine (C-C motif) ligand 24 (CCL24, eotaxin-2) is a CC chemokine that recruits and activates cells bearing the CC chemokine receptor 3, which play a major role in asthma. Previously, we observed a significant association between a single nucleotide polymorphism (SNP) in eotaxin-2 (CCL24+1272A--> G) and a lower risk of asthma. Consequently, this study has followed up on those genetic effects by evaluating the association between the SNP and plasma eotaxin-2 concentration in 172 asthmatics and 135 normal controls. Asthmatics had significantly higher plasma eotaxin-2 levels than did normal controls (P=0.02). The SNP (CCL24+1272A--> G) and two haplotypes (ht2 and ht6) were strongly associated with plasma eotaxin-2 levels in asthmatics (CCL24+1272A--> G: P=0.006, ht2: P=0.006, and ht6: P=0.002). The CCL24+1272A--> G allele and the ht2 and ht6 haplotypes showed a gene-dose effect on the plasma eotaxin-2 levels in asthmatics (P=0.005-0.032). In conclusion, the susceptibility of patients with asthma to high eotaxin-2 production may be due to genetic effects of the CCL24+1272A--> G polymorphism, ht2 and ht6 haplotypes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15744457     DOI: 10.1007/s10038-005-0230-3

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  31 in total

1.  Evidence for systemic rather than pulmonary effects of interleukin-5 administration in asthma.

Authors:  E L van Rensen; R G Stirling; J Scheerens; K Staples; P J Sterk; P J Barnes; K F Chung
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

2.  IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK.

Authors:  Paul E Moore; Trudi L Church; David D Chism; Reynold A Panettieri; Stephanie A Shore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-04       Impact factor: 5.464

3.  CC chemokine receptor-3 undergoes prolonged ligand-induced internalization.

Authors:  N Zimmermann; J J Conkright; M E Rothenberg
Journal:  J Biol Chem       Date:  1999-04-30       Impact factor: 5.157

4.  Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population.

Authors:  L Excoffier; M Slatkin
Journal:  Mol Biol Evol       Date:  1995-09       Impact factor: 16.240

5.  Molecular cloning and characterization of a novel human CC chemokine, SCYA26.

Authors:  R F Guo; P A Ward; S M Hu; J E McDuffie; M Huber-Lang; M M Shi
Journal:  Genomics       Date:  1999-06-15       Impact factor: 5.736

6.  Molecular cloning of a novel human CC chemokine (Eotaxin-3) that is a functional ligand of CC chemokine receptor 3.

Authors:  M Kitaura; N Suzuki; T Imai; S Takagi; R Suzuki; T Nakajima; K Hirai; H Nomiyama; O Yoshie
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

7.  Tissue-specific expression of p53 in transgenic mice is regulated by intron sequences.

Authors:  G Lozano; A J Levine
Journal:  Mol Carcinog       Date:  1991       Impact factor: 4.784

8.  Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils.

Authors:  P D Ponath; S Qin; D J Ringler; I Clark-Lewis; J Wang; N Kassam; H Smith; X Shi; J A Gonzalo; W Newman; J C Gutierrez-Ramos; C R Mackay
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

9.  Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils.

Authors:  P D Ponath; S Qin; T W Post; J Wang; L Wu; N P Gerard; W Newman; C Gerard; C R Mackay
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

10.  Cloning, expression, and characterization of the human eosinophil eotaxin receptor.

Authors:  B L Daugherty; S J Siciliano; J A DeMartino; L Malkowitz; A Sirotina; M S Springer
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more
  9 in total

1.  Genetic interactions model among Eotaxin gene polymorphisms in asthma.

Authors:  June-Hyuk Lee; Jason H Moore; Sung-Woo Park; An-Soo Jang; Soo-Taek Uh; Yong Hoon Kim; Choon-Sik Park; Byung Lae Park; Hyoung Doo Shin
Journal:  J Hum Genet       Date:  2008-08-20       Impact factor: 3.172

2.  Eotaxin-2 increased toll-like receptor 4 expression in endothelial cells in vitro and exacerbates high-cholesterol diet-induced atherogenesis in vivo.

Authors:  Chien-Sung Tsai; Chun-Yao Huang; Chien-Ho Chen; Yi-Wen Lin; Chun-Ming Shih; Nai-Wen Tsao; Kuang-Hsing Chiang; Chi-Yuan Lee; Hellen Jeng; Feng-Yen Lin
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

Review 3.  Activation states of blood eosinophils in asthma.

Authors:  M W Johansson
Journal:  Clin Exp Allergy       Date:  2014-04       Impact factor: 5.018

4.  Eotaxin-2 induces monocytic apoptosis in patients who have undergone coronary artery bypass surgery and in THP-1 cells in vitro regulated by thrombomodulin.

Authors:  Yi-Wen Lin; Chun-Yao Huang; Chun-Min Shih; Yi-Ting Tsai; Chin-Sheng Lin; Chih-Yuan Lin; Chi-Yuan Li; Shih-Hurng Loh; Cheng-Yen Lin; Feng-Yen Lin; Chien-Sung Tsai
Journal:  Am J Transl Res       Date:  2018-10-15       Impact factor: 4.060

Review 5.  Immune-related gene polymorphisms in pulmonary diseases.

Authors:  Dhirendra P Singh; Prathyusha Bagam; Malaya K Sahoo; Sanjay Batra
Journal:  Toxicology       Date:  2017-03-30       Impact factor: 4.221

Review 6.  The chemokine network. II. On how polymorphisms and alternative splicing increase the number of molecular species and configure intricate patterns of disease susceptibility.

Authors:  R Colobran; R Pujol-Borrell; M P Armengol; M Juan
Journal:  Clin Exp Immunol       Date:  2007-10       Impact factor: 4.330

7.  Genome wide association identifies PPFIA1 as a candidate gene for acute lung injury risk following major trauma.

Authors:  Jason D Christie; Mark M Wurfel; Rui Feng; Grant E O'Keefe; Jonathan Bradfield; Lorraine B Ware; David C Christiani; Carolyn S Calfee; Mitchell J Cohen; Michael Matthay; Nuala J Meyer; Cecilia Kim; Mingyao Li; Joshua Akey; Kathleen C Barnes; Jonathan Sevransky; Paul N Lanken; Addison K May; Richard Aplenc; James P Maloney; Hakon Hakonarson
Journal:  PLoS One       Date:  2012-01-25       Impact factor: 3.240

8.  Effect and mechanism of lipopolysaccharide on allergen-induced interleukin-5 and eotaxins production by whole blood cultures of atopic asthmatics.

Authors:  J-W Min; S-M Park; T Y Rhim; S-W Park; A-S Jang; S-T Uh; C-S Park; I Y Chung
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

9.  Genetic polymorphisms and associated susceptibility to asthma.

Authors:  Michael E March; Patrick Ma Sleiman; Hakon Hakonarson
Journal:  Int J Gen Med       Date:  2013-04-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.